<DOC>
	<DOCNO>NCT01968135</DOCNO>
	<brief_summary>The specific aim determine woman use Etonogestrel ( ENG ) contraceptive implant report bleeding-spotting episode least seven day stop bleeding within 3 day begin 14-day course combine oral hormonal steroid , compare woman receive 14 day placebo .</brief_summary>
	<brief_title>Does Concomitant Use Combined Oral Hormonal Steroids Stop Bleeding Women Using Etonogestrel Implants ( Implanon/Nexplanon® ) ? : A Randomized Controlled Study</brief_title>
	<detailed_description>The ENG contraceptive implant ( Implanon/Nexplanon® ) , silicone- free , single rod subdermal contraceptive implant contain 68 mg etonogestrel , approve use three year , one effective form contraception available ( 1 ) . ENG contraceptive implant easily insert remove ( 1,2 ) , offer quick return fertility ( 2 ) , cost-effective cost-saving ( 3,4 ) offer non-contraceptive benefit improvement pain patient complaint dysmenorrhea ( 5 ) . Hypothesis : Women use ENG contraceptive implant report bleeding-spotting episode least seven day likely stop bleeding within 3 day begin 14-day course combine oral hormonal steroid compare woman receive 14 day placebo .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Etonogestrel</mesh_term>
	<mesh_term>Contraceptives , Oral , Combined</mesh_term>
	<criteria>All female English Spanish speak woman age 1844 use ENG contraceptive implant complain bothersome bleed current bleeding episode least seven day invite participate . Category 3 4 contraindication estrogen therapy accord Centers Disease Control 2010 Medical Eligibility Criteria . Category 3 contraindication : less 1 month postpartum breastfeeding , less 21 day postpartum breastfeed , history Deep Vein Thrombosis ( DVT ) /Pulmonary Embolism ( PE ) anticoagulant therapy risk factor , Deep venous thrombosis/Pulmonary Embolus establish anticoagulant therapy risk factor , history malabsorptive bariatric surgery , great equal month post peripartum cardiomyopathy normal mildly impaired cardiac function , great equal 35 year old less 15 cigarette smoke per day , multiple risk factor arterial cardiovascular disease , adequately control hypertension , blood pressure 140159/9099 mm Hg , migraine without aura le 35 year old , past breast cancer evidence recurrent disease 5 year , diabetes retinopathy , neuropathy , nephropathy ( category 3 4 depend severity ) , diabetes great 20 year duration associate vascular disease , medically treat symptomatic gallbladder disease current symptomatic gallbladder disease , past combine oral contraceptive pill relate cholestasis , acute viral hepatitis , hepatocellular adenoma , hepatoma , use ritonavirboosted protease inhibitor , anticonvulsant therapy use include phenytoin , carbamazepine , barbiturate , primidone , topiramate , oxcarbazepine , lamotrigine , use Rifampicin , Category 4 contraindication : le 6 month post peripartum cardiomyopathy normal mildly impaired cardiac function , time follow peripartum cardiomyopathy moderately severely impaired cardiac function , great equal 35 year old great 15 cigarette smoke per day , multiple risk factor arterial cardiovascular disease , blood pressure great equal 160/100 mm Hg , high risk recurrent DVT/PE , acute DVT/PE , DVT/PE establish anticoagulant therapy great equal 1 risk factor recurrent DVT/PE , major surgery/prolonged immobilization , know thrombogenic mutation , current history ischemic heart disease , history stroke , complicate valvular heart disease , systemic lupus erythematosus ( SLE ) positive unknown antiphospholipid antibody , migraine without aura great equal 35 year old , migraine aura age , current breast cancer , complicate solid organ transplantation Body mass index ( BMI ) great 35 . A systolic blood pressure great 135 2 occasion . assure measurement separate interval least 15 minute . A diastolic blood pressure great 85 2 occasion . assure measurement separate interval least 15 minute . A positive pregnancy test . A positive chlamydia test . Unable unwilling swallow pill . A medical condition deem severed physician investigator . A participant take liver enzyme induce drug . A known allergy levonorgestrel ethinyl estradiol . An abnormal speculum exam ( i.e . bleed ectropion cervical mass ) . Does meet appropriate cervical cytology screen guideline . Cervical procedure do past 3 month . On concurrent hormonal contraceptive unwilling discontinue . Breast lesion</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>